PredicT: Preoperative Diagnostic Tests for Pulmonary Risk Assessment in COPD

Sponsor
Universitätsklinikum Hamburg-Eppendorf (Other)
Overall Status
Completed
CT.gov ID
NCT02566343
Collaborator
(none)
365
1
20
18.3

Study Details

Study Description

Brief Summary

This prospective study intends to investigate the incidence of postoperative pulmonary complications (PPC) or in-hospital mortality in patients with COPD or at risk for COPD undergoing high-risk noncardiac major surgery and to identify relevant risk factors. This study aims to quantify and compare the diagnostic performance of preoperative functional tests, exercise capacity, clinical assessment tests and predictive scoring systems to predict PPC or in-hospital mortality in these patients.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    COPD is associated with high perioperative morbidity and mortality and PPC frequently occur in these patients. However, concepts for preoperative pulmonary risk assessment and the predictive value of routine preoperative exercise capacity, clinical assessment and pulmonary function tests are still poorly characterized.

    Objectives:
    • To determine the incidence of the composite end point of PPC or all cause in-hospital mortality in patients with confirmed COPD (spirometry) and patients with clinical risk factors in whom spirometry disproved COPD.

    • To determine the predictive value of exercise capacity, clinical assessment tests, pulmonary function tests and predictive scoring systems to predict the composite end point in these patients.

    • To identify relevant risk factors and predictors associated with the composite end point.

    Methodology:

    Prospective single-centre observational study

    All patients receive a structured preoperative pulmonary risk assessment with:
    1. standardized clinical questionnaire

    2. COPD Assessment Test (CAT™)

    3. exercise capacity (symptom-limited stair climbing)

    4. spirometry

    5. capillary blood gas Analysis

    Postoperative follow-up is planned between the 2nd and 5th day after extubation.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    365 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Preoperative Diagnostic Tests for Pulmonary Risk Assessment in Patients With Chronic Obstructive Pulmonary Disease (COPD) Undergoing Major Surgery
    Study Start Date :
    Nov 1, 2014
    Actual Primary Completion Date :
    Jul 1, 2016
    Actual Study Completion Date :
    Jul 1, 2016

    Arms and Interventions

    Arm Intervention/Treatment
    COPD cohort

    confirmed COPD: 240 patients with COPD confirmed by spirometry undergoing high-risk noncardiac major surgery in the University Medical Center Hamburg-Eppendorf will be included in this group.

    Control cohort

    disproved COPD: 80 patients without COPD (clinical risk factors but negative spirometry) undergoing high-risk noncardiac major surgery will be included as a control group.

    Outcome Measures

    Primary Outcome Measures

    1. Composite end point of postoperative pulmonary complications (PPC) or all cause in-hospital mortality [until hospital discharge up to 6 months after surgery]

    Secondary Outcome Measures

    1. Forced expiratory volume in one second to forced vital capacity ratio (FEV1/FVC) and FEV1 % predicted [within 1 week after extubation]

    2. Carbon dioxide (pCO2) and oxygen (pO2) partial pressures from blood gas analysis [within 1 week after extubation]

    3. Postoperative new respiratory symptoms (e.g. dyspnea or wheezing) or treatment for exacerbation (e.g. new systemic glucocorticosteroids or bronchodilators) [until hospital discharge up to 6 months after surgery]

    4. New pulmonary radiological findings (e.g. pneumonia or pneumothorax) [until hospital discharge up to 6 months after surgery]

    5. Duration of hospitalization (days) [until hospital discharge up to 6 months after surgery]

    6. Duration of postoperative respirator support (h) [until hospital discharge up to 6 months after surgery]

    7. Length of stay in the intensive care unit (days) [until hospital discharge up to 6 months after surgery]

    8. Frequency of unplanned intensive care unit admission, prolonged oxygen requirement, reintubation, non-invasive ventilation (NIV) or extracorporeal lung assist [until hospital discharge up to 6 months after surgery]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 18 years and older

    • High-risk noncardiac major surgery with an anticipated operation time ≥ 120 minutes and/or planned postoperative intensive care unit admission

    • Typical clinical signs for COPD (dyspnea, chronic cough, chronic sputum production, exposure to risk factors)

    • Confirmed COPD (medical history) or clinical risk factors for COPD

    • Positive COPD Assessment Test (CAT™)

    Exclusion Criteria:
    • < 18 Years

    • Pregnancy

    • Lack of cooperation

    • Inability to provide functional tests like spirometry or stairclimbing

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf Hamburg Germany 20246

    Sponsors and Collaborators

    • Universitätsklinikum Hamburg-Eppendorf

    Investigators

    • Principal Investigator: Martin Petzoldt, MD, Universitätsklinikum Hamburg-Eppendorf
    • Principal Investigator: Christian Zöllner, MD, Universitätsklinikum Hamburg-Eppendorf

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Universitätsklinikum Hamburg-Eppendorf
    ClinicalTrials.gov Identifier:
    NCT02566343
    Other Study ID Numbers:
    • PV4743
    First Posted:
    Oct 2, 2015
    Last Update Posted:
    Jun 24, 2020
    Last Verified:
    Jun 1, 2016
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Universitätsklinikum Hamburg-Eppendorf
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 24, 2020